Ching-Wei D. Tzeng

94 posts

Ching-Wei D. Tzeng

Ching-Wei D. Tzeng

@CDTzeng

HPB Surgical Oncologist @MDAndersonNews| Assistant Coach| Boba tea connoisseur

เข้าร่วม Ağustos 2021
523 กำลังติดตาม1.3K ผู้ติดตาม
Ching-Wei D. Tzeng
Ching-Wei D. Tzeng@CDTzeng·
Kicking off day 3 of Colorectal Liver Mets Consensus Conf with keynote lecture from Prof Mazzaferro. Then panels 7-8 on Transplant and Surveillance #CLMCC2026 @IHPBA @EAHPBA
Ching-Wei D. Tzeng tweet mediaChing-Wei D. Tzeng tweet mediaChing-Wei D. Tzeng tweet media
English
1
4
25
1.4K
Ching-Wei D. Tzeng
Ching-Wei D. Tzeng@CDTzeng·
Colorectal Liver Mets Consensus Conf Feb 24-26. #CLMCC2026 --- Just one day before pre-meeting Grand Rounds Feb 23 with @JeanneTie for the @VautheyMD Visiting Professorship. Registration still available (including virtual platform) lnkd.in/gs7mBKES -- see you soon!
Ching-Wei D. Tzeng tweet mediaChing-Wei D. Tzeng tweet mediaChing-Wei D. Tzeng tweet mediaChing-Wei D. Tzeng tweet media
English
0
12
19
1.8K
Ching-Wei D. Tzeng
Ching-Wei D. Tzeng@CDTzeng·
Next week-- Colorectal Liver Mets Consensus Conference (Feb 24-26, Houston, TX). Come join colleagues from 26 countries! Registration: lnkd.in/gs7mBKES - LIVESTREAM webinar available. Sneak peak below:
Ching-Wei D. Tzeng tweet mediaChing-Wei D. Tzeng tweet media
English
0
22
43
3.1K
Ching-Wei D. Tzeng
Ching-Wei D. Tzeng@CDTzeng·
3 weeks to go -- come join attendees from 26 countries! If you are interested in the current landscape of modern multidisciplinary management of Colorectal Liver Mets, this Consensus Conference is for you. Registration: mdanderson.cloud-cme.com/CLMCC2026
Ching-Wei D. Tzeng tweet media
English
1
18
46
3.4K
Ching-Wei D. Tzeng
Ching-Wei D. Tzeng@CDTzeng·
Thanks @hitoen9 - 1 week left to submit!
Ching-Wei D. Tzeng tweet media
Hitoe Nishino@hitoen9

Attending the CLM Consensus Conference 2026 in Houston 🇺🇸 Chaired by Prof. Jean-Nicolas Vauthey, Prof. Pierre-Alain Clavien & Prof. Scott Kopetz ✨ Excited to learn the cutting edge of #CLM management from these living legends 🙌🏼 Any #HPB colleagues from 🇯🇵 or elsewhere joining 🤗? 📝 Oral & poster submissions open ⏰ LAST CALL: Jan 23, 2026 👉 mdanderson.cloud-cme.com/course/courseo…

English
0
1
5
516
Hitoe Nishino
Hitoe Nishino@hitoen9·
Attending the CLM Consensus Conference 2026 in Houston 🇺🇸 Chaired by Prof. Jean-Nicolas Vauthey, Prof. Pierre-Alain Clavien & Prof. Scott Kopetz ✨ Excited to learn the cutting edge of #CLM management from these living legends 🙌🏼 Any #HPB colleagues from 🇯🇵 or elsewhere joining 🤗? 📝 Oral & poster submissions open ⏰ LAST CALL: Jan 23, 2026 👉 mdanderson.cloud-cme.com/course/courseo…
Hitoe Nishino tweet media
English
1
6
18
1.7K
Ching-Wei D. Tzeng รีทวีตแล้ว
SocAsianAcadSurg
SocAsianAcadSurg@AsianAcadSurg·
Calling all junior faculty! Applications open for the SAAS 2025 Early Career Development/Junior Faculty Award 🗓Deadline: Dec 1, 2024 🔗Application Link: asiansurgeon.org/awards/junior-…"
SocAsianAcadSurg tweet media
English
0
6
15
1.7K
Ching-Wei D. Tzeng
Ching-Wei D. Tzeng@CDTzeng·
Thanks @mikeblez @PeterKimMDVGH @UBC for incredible opportunity to exchange ideas from @MDAndersonNews with your faculty, @ubcgensurg Residents, and @AHPBA @ASTSChimera @SocSurgOnc Fellows! What an amazing group and training program y’all have!
Michael Bleszynski@mikeblez

It was a honour and privilege hosting ⁦@CDTzeng⁩ at VGH, ⁦@UBC⁩ ⁦@ubcgensurg⁩ for our Provincial General Surgery Grand Rounds. It was an inspiring talk about Pancreas ERAS pathways and a phenomenal 2 days with ⁦@CDTzeng⁩. ⁦@AHPBA⁩ ⁦

English
0
3
23
1.9K
Ching-Wei D. Tzeng
Ching-Wei D. Tzeng@CDTzeng·
@AnnSurgOncol here's another debate: high-res CT alone (cheaper/faster) vs. also MRI (more costly/slower)? Ultimately, "recurrence" is actually "residual" disease. Does it make a difference which modality we use upfront staging (assuming liver protocol [not ER quality] CT)? @SocietyAbdRad
English
0
0
1
114
Annals of Surgical Oncology
Annals of Surgical Oncology@AnnSurgOncol·
HCC can recur in up to 80% treated with first line resection or ablation. How does the “filed defect” leading to HCC in the patient’s native liver impact your local treatment decisions vs considerations for transplant? #ASOchat
English
3
2
4
1.1K
Annals of Surgical Oncology
Annals of Surgical Oncology@AnnSurgOncol·
A similar study in Annals of Surgical in 2010 (ow.ly/ijMo50TfOqj ) with same inclusion criteria for HCC found OS and RFS were significantly lower in the ablation group compared to the surgical group. Why do you think the findings were different 14 years later? #ASOchat
Annals of Surgical Oncology tweet media
English
5
2
10
1.9K
Annals of Surgical Oncology
Annals of Surgical Oncology@AnnSurgOncol·
Thank you so much for joining our @AnnSurgOncol Hepatocellular Carcinoma #ASOchat. Feel free to keep the great discussion going and follow us for more surgical oncology research news!
English
2
2
11
2.8K
Ching-Wei D. Tzeng
Ching-Wei D. Tzeng@CDTzeng·
@AnnSurgOncol my interpretation: both resection / ablation are salvageable w/ min diff in OS vs. primary liver tx upfront (not prospective, small sample size). You don't have to feel bad about not upfront transplant a pt w/3cm unifocal HCC. If recurs, go to transplant. @ASTSChimera
English
1
3
8
628
Annals of Surgical Oncology
Annals of Surgical Oncology@AnnSurgOncol·
If there is a recurrence of HCC after treatment, do you consider transplant if the patient may be a candidate? What are the realities for your availability for this treatment option? #ASOchat
English
5
2
4
956